Managing Alkaptonuria in Absence of Appropriate Medication: A Case Report and Review of Literature

Clin Med Res. 2024 Jun;22(2):107-111. doi: 10.3121/cmr.2024.1867.

Abstract

Alkaptonuria is an inborn error of metabolism inherited as an autosomal recessive disorder due to a mutation in the homogentisic acid dioxygenase gene. It occurs rarely (global prevalence of alkaptonuria is 1 in 100,000 to 250,000), and mainly affects the joints and connective tissue of the body due to deposition of homogentisic acid giving affected areas a blue-black discoloration (ochronosis).In this case report, we present a male patient, aged 47 years, with joint and scleral involvement. He had been diagnosed many years ago with the disease by gas chromatography. His symptoms kept progressively worsening since he was recently prescribed physiotherapy and vitamin C for his disease, which has not been shown to be an effective treatment. A main reason for his disease deterioration was also the lack of nitisinone availability in his home country, as well as in the subcontinent region generally. We also presen a summary of some previously reported cases and treatment regimens to compare our case and present the comparison as a learning source for future physicians.

Keywords: Metabolism; Ochronosis; Vitamin C.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Alkaptonuria* / diagnosis
  • Alkaptonuria* / drug therapy
  • Ascorbic Acid / therapeutic use
  • Cyclohexanones / therapeutic use
  • Homogentisic Acid
  • Humans
  • Male
  • Middle Aged
  • Nitrobenzoates / therapeutic use
  • Ochronosis
  • Physical Therapy Modalities

Substances

  • nitisinone
  • Ascorbic Acid
  • Nitrobenzoates
  • Cyclohexanones
  • Homogentisic Acid